Pathosignificance of cardiac aldosterone synthesis in heart failure
心脏醛固酮合成在心力衰竭中的病理意义
基本信息
- 批准号:13670729
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2001
- 资助国家:日本
- 起止时间:2001 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Extra-adrenal aldosterone synthase system has been closed-up recently and we also showed that aldosterone was synthesized and secreted from human failing or hypertensive heart. And we recently showed that cardiac aldosterone synthesis is suppressed by ACE inhibitor.Still more detailed examination was performed about the human cardiac aldosterone synthesis. The cardiac tissue was extracted from the autopsy of patients with heart failure or non-heart failure and we examined gene expression of CYP11B2, aldosterone synthase. Since the expression of CYP11B2 was very small, we could not detect them by usual real-time RT-PCR method. Then, we newly modified real-time RT-PCR and we were able to detect the gene expression and quantified them. Consequently, the gene expression of CYP11B2 was up-regulated in the failing heart compared with the non-failing heart.Next, the inhibitory effect of natriuretic peptide (NP) on cardiac aldosterone synthesis was examined using neonatal rat cardiocyte culture system. By blocking endogenous natriuretic peptide effect with HS142-1, a GC-A receptor antagonist, CYP11B2 gene was significantly expressed. Also, exogenous natriuretic peptide suppressed the CYP11B2 gene expression, the dose of which was a commonly used concentration level in the treatment of heart failure. These results indicate that cardiac aldosterone synthesis is suppressed by NP and the balancing between aldosterone and NP would be very important in heart failure status.As for pathophysiological roles of aldosterone, we recently found that aldosterone augments the ACE gene expression in neonatal rat cardiocytes, making a vicious cycle between tissue RAAS.As mentioned above, we have studied about cardiac aldosterone synthesis and its pathophysiological significance in heart failure. In he renin-angiotensin-aldosterone system, not only angiotensin II but also aldosterone would provide unfavorable effects directly. The aspect of a paradigm shift has just been presented.
最近,肾上腺外醛固酮合酶系统已被封闭,我们还发现人类衰竭或高血压的心脏也可以合成和分泌醛固酮。我们最近发现ACE抑制剂可以抑制心脏醛固酮的合成。对人类心脏醛固酮的合成进行了更详细的检查。从心力衰竭或非心力衰竭患者的尸检中提取心脏组织,我们检查了 CYP11B2(醛固酮合酶)的基因表达。由于CYP11B2的表达量很小,我们无法通过常规的实时RT-PCR方法检测到它们。然后,我们新修改了实时 RT-PCR,我们能够检测基因表达并对其进行定量。因此,与正常心脏相比,衰竭心脏中CYP11B2的基因表达上调。接下来,利用新生大鼠心肌细胞培养系统检测利尿钠肽(NP)对心脏醛固酮合成的抑制作用。通过GC-A受体拮抗剂HS142-1阻断内源性利钠肽作用,CYP11B2基因显着表达。另外,外源性利钠肽可抑制CYP11B2基因的表达,其剂量是治疗心力衰竭常用的浓度水平。这些结果表明,心脏醛固酮合成受到NP抑制,醛固酮和NP之间的平衡在心力衰竭状态中非常重要。 至于醛固酮的病理生理作用,我们最近发现醛固酮增强新生大鼠心肌细胞中ACE基因的表达,使得组织RAAS之间的恶性循环。如上所述,我们研究了心脏醛固酮的合成及其在心力衰竭中的病理生理学意义。在肾素-血管紧张素-醛固酮系统中,不仅血管紧张素II,醛固酮也会直接产生不良作用。刚刚提出了范式转变的方面。
项目成果
期刊论文数量(21)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
M. Yoshimura, Y. Mizuno, M. Nakayama, T. Sakamoto, S. Sugiyama, H. Kawano, H. Soejima, N. Hirai, Y. Saito, K. Nakao & H. Yasue. Ogawa: "B-type natriuretic peptide as a sensitive marker of time- and dose-dependent effects of ACE inhibitor in patients with
M. Yoshimura、Y. Mizuno、M. Nakayama、T. Sakamoto、S. Sugiyama、H. Kawano、H. Soejima、N. Hirai、Y. Saito、K. Nakao
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
T. Sakamoto, Y. Mizuno, H. Ogawa, M. Yoshimura, K. Kugiyama & H. Yasue: "B-type natriuretic peptide after percutaneous transluminal septal myocardial ablation"Int J Cardiol. 83(2). 151-158 (2002)
T.坂本、Y.水野、H.小川、M.吉村、K.钉山
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Mizuno Y, et al.: "Aldosterone Production is Activated in the Failing Ventricles in Humans"Circulation. 103(1). 72-77 (2001)
Mizuno Y 等人:“醛固酮的产生在人类衰竭心室中被激活”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
M. Yoshimura, H. Yasue & H. Ogawa: "Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure"Can J Pharma Physiol. 79 (8). 730-735 (2001)
M.吉村,H.安江
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yamamoto, et al.: "Aldosterone is activated in the ventricles in patients with essential hypertension (accept後の校正中にて仮)"Hypertension. (In press).
Yamamoto 等人:“原发性高血压患者的心室中醛固酮被激活(接受后校对期间临时)”高血压(正在出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIMURA Michihiro其他文献
YOSHIMURA Michihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIMURA Michihiro', 18)}}的其他基金
Research for the mechanism of aldosterone synthesis in the adrenal gland and the heart.
研究肾上腺和心脏醛固酮合成机制。
- 批准号:
23591089 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The pathophysiological role of aldosterone in cardiovascular disease.
醛固酮在心血管疾病中的病理生理学作用。
- 批准号:
20590841 - 财政年份:2008
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Relation between cardiovascular diseases and cardiac hormones
心血管疾病与心脏激素的关系
- 批准号:
17390233 - 财政年份:2005
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study of Cardiac Steroidogenesis
心脏类固醇生成的研究
- 批准号:
15390249 - 财政年份:2003
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular biological analysis of coronary spasm
冠状动脉痉挛的分子生物学分析
- 批准号:
11670694 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Genetic analysis of endothelial nitric oxide synthase in patients with coronary spastic angina
冠状动脉痉挛性心绞痛患者内皮型一氧化氮合酶基因分析
- 批准号:
09670732 - 财政年份:1997
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Expression of natriuretic peptides in heart failure
心力衰竭中利尿钠肽的表达
- 批准号:
07670795 - 财政年份:1995
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
胞质分裂因子DOCK2介导心脏CD8+T细胞释放IFN-γ促进成纤维细胞抗原提呈在心力衰竭中的作用及机制研究
- 批准号:82300297
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
适当冷暴露通过肠道菌群调控心脏免疫微环境改善心梗后心室重构和心力衰竭的作用与机制
- 批准号:82330014
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
肾上腺髓质素在增强型体外反搏改善缺血性心力衰竭患者心脏收缩功能中的作用研究
- 批准号:82300432
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV1阳性心脏感觉神经元介导Th17炎症在梗死后心力衰竭中的作用与机制
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
线粒体NAD+转运蛋白MCART1调控心脏代谢重构在心力衰竭中的作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Processivity and Catalytic Mechanism of Aldosterone Synthase
醛固酮合酶的持续合成能力和催化机制
- 批准号:
10600520 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
High-throughput Flow Culture of 3D Human PKD Models for Therapeutic Screening
用于治疗筛选的 3D 人体 PKD 模型的高通量流式培养
- 批准号:
10649222 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Renal Denervation in Heart Failure with Preserved Ejection Fraction
肾去神经术治疗射血分数保留的心力衰竭
- 批准号:
10836312 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Exploration of novel block-and-lock agents alone and in combination for HIV remission in humanized mice
探索新型阻断剂和联合用药在人源化小鼠中缓解 HIV
- 批准号:
10714365 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别: